# Transgene

> Developing cancer immunotherapies

Business model and tags: B2B, Has physical offices, Publicly traded, Healthtech, Sales-led purchase, Pharma & life sciences, Has in-house R&D

## About Transgene

Biotechnology company specializing in developing innovative cancer immunotherapies to treat cancer effectively and provide hope for patients

## Key facts

- **Industry**: Biotechnology
- **Company size**: 51–250 employees
- **Headquarters**: Illkirch-Graffenstaden, Grand Est, France
- **Founded**: 1979
- **Revenue**: €6.1M (FY2024, filed accounts, INPI)
- **SIREN**: [317540581](https://annuaire-entreprises.data.gouv.fr/entreprise/317540581)
- **Website**: [transgene.com](https://www.transgene.com/)
- **LinkedIn**: [linkedin.com/company/transgene](https://www.linkedin.com/company/transgene)

## Transgene at a glance

Transgene is a B2B company in the Biotechnology industry, headquartered in Illkirch-Graffenstaden, Grand Est, France.

Transgene was founded in 1979.

Transgene has 51–250 employees.

Transgene's revenue is €6.1M (FY2024, filed accounts, INPI).

Transgene's SIREN number is 317540581.

## Frequently asked questions about Transgene

### What is Transgene's revenue?

Transgene's revenue is €6.1M (FY2024, filed accounts, INPI).

### How many employees does Transgene have?

Transgene has 51–250 employees.

### Where is Transgene headquartered?

Transgene is headquartered in Illkirch-Graffenstaden, Grand Est, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/transgene
